APA (7th ed.) Citation

SX, W., YL, T., TS, G., N, Z., GQ, Z., FY, X., . . . YP, M. (2026). Medial retropharyngeal nodal region sparing radiotherapy in nasopharyngeal carcinoma: Five year analysis of open label, non-inferiority, multicentre, randomised phase 3 trial. BMJ (Clinical research ed.), 392, e086050. https://doi.org/10.1136/bmj-2025-086050

Chicago Style (17th ed.) Citation

SX, Wang, et al. "Medial Retropharyngeal Nodal Region Sparing Radiotherapy in Nasopharyngeal Carcinoma: Five Year Analysis of Open Label, Non-inferiority, Multicentre, Randomised Phase 3 Trial." BMJ (Clinical Research Ed.) 392 (2026): e086050. https://doi.org/10.1136/bmj-2025-086050.

MLA (9th ed.) Citation

SX, Wang, et al. "Medial Retropharyngeal Nodal Region Sparing Radiotherapy in Nasopharyngeal Carcinoma: Five Year Analysis of Open Label, Non-inferiority, Multicentre, Randomised Phase 3 Trial." BMJ (Clinical Research Ed.), vol. 392, 2026, p. e086050, https://doi.org/10.1136/bmj-2025-086050.